Pacific Biosciences of California, Inc. (PACB) was a big mover last session with its shares rising over 7% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This reverses the recent trend of the company, as the stock has lost over 9% in the past one-month time frame.
This biotechnology company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Pacific Biosciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
A Med-Instruments stock worth considering is Cepheid (CPHD) with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment